Original language | English |
---|---|
Pages (from-to) | 730-731 |
Number of pages | 2 |
Journal | Bipolar Disorders |
Volume | 23 |
Issue number | 7 |
DOIs | |
Publication status | Published - 11-2021 |
All Science Journal Classification (ASJC) codes
- Psychiatry and Mental health
- Biological Psychiatry
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Bipolar Disorders, Vol. 23, No. 7, 11.2021, p. 730-731.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Omega-3 fatty acids for treating residual depressive symptoms in adult patients with bipolar disorder
T2 - A systematic review and meta-analysis of double-blind randomized, placebo-controlled trials
AU - Kishi, Taro
AU - Sakuma, Kenji
AU - Okuya, Makoto
AU - Ikeda, Masashi
AU - Iwata, Nakao
N1 - Funding Information: The authors have declared that there are no conflicts of interest relating to the subject of this study. Interests from the past 3 years are as follows. Dr. Kishi received speaker's honoraria from Sumitomo Dainippon, Otsuka, Eisai, Daiichi Sankyo, Janssen, Takeda, Kyowa, Kissei, Meiji, Pfizer, Mochida, Eli Lilly, MSD, Janssen, and Tanabe‐Mitsubishi (Yoshitomi); as well as research grants from Eisai, the Japanese Ministry of Health, Labour and Welfare, Grant‐in‐Aid for Scientific Research (C), and Fujita Health University School of Medicine. Dr. Sakuma has received speaker's honoraria from Eisai, Kissei, Meiji, Otsuka, and Torii and has received a Fujita Health University School of Medicine Research Grant for Early‐Career Scientists, as well as a Grant‐in‐Aid for Young Scientists (B). Dr. Okuya has received speaker's honoraria from Meiji and has received a Fujita Health University School of Medicine Research Grant for Early‐Career Scientists, as well as a Grant‐in‐Aid for Young Scientists. Prof. Ikeda has received speaker's honoraria from Tanabe‐Mitsubishi (Yoshitomi), Otsuka, and Takeda; research grants from Senshin Medical Research Foundation and Strategic Research Program for Brain Sciences (SRPBS) from the Japan Agency for Medical Research and Development (AMED) under Grant Numbers JP20dm0107097 and JP21wm0425008. Prof. Iwata received speaker's honoraria from Sumitomo Dainippon, Eli Lilly, Janssen, Meiji, Otsuka, Takeda, and Pfizer as well as research grants from Dainippon Sumitomo, Eisai, Otsuka, and Takeda; along with research grants from Daiichi Sankyo, Takeda, Dainippon Sumitomo Eisai, Meiji Tanabe‐Mitsubishi, and Otsuka.
PY - 2021/11
Y1 - 2021/11
UR - http://www.scopus.com/inward/record.url?scp=85110961012&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85110961012&partnerID=8YFLogxK
U2 - 10.1111/bdi.13115
DO - 10.1111/bdi.13115
M3 - Letter
C2 - 34228881
AN - SCOPUS:85110961012
SN - 1398-5647
VL - 23
SP - 730
EP - 731
JO - Bipolar Disorders
JF - Bipolar Disorders
IS - 7
ER -